{"id":45022,"date":"2024-05-08T16:59:00","date_gmt":"2024-05-08T14:59:00","guid":{"rendered":"https:\/\/www.stille.se\/us\/mfn_news\/report-from-the-annual-general-meeting-2024-in-stille\/"},"modified":"2024-05-08T16:59:00","modified_gmt":"2024-05-08T14:59:00","slug":"report-from-the-annual-general-meeting-2024-in-stille","status":"publish","type":"mfn_news","link":"https:\/\/www.stille.se\/us\/news\/report-from-the-annual-general-meeting-2024-in-stille\/","title":{"rendered":"Report from the Annual General Meeting 2024 in Stille"},"content":{"rendered":"
\n

The Annual General Meeting 2024 in Stille AB was held on Wednesday, May 8th at Eskilstunav\u00e4gen 34 in Torsh\u00e4lla. The main resolutions passed at the Annual General Meeting were as follows. More detailed information about the contents of the resolutions may be obtained from the complete notice of the Annual General Meeting and the complete proposals, which are available on the company\u2019s website.<\/strong><\/p>\n<\/div>\n

\n

The Annual General Meeting adopted the presented Income Statement and Balance Sheet as well as the Consolidated Income Statement and Consolidated Balance Sheet for 2023. The Annual General Meeting approved the Board of Directors' proposal that no dividend shall be paid for the financial year 2023 and discharged the members of the Board of Directors and the President from liability for the past year.<\/p>\n

The Annual General Meeting resolved that the Board of Directors shall consist of five members without Deputies and that the number of Auditors shall be one without a Deputy Auditor.<\/p>\n

The Annual General Meeting resolved that the remuneration to the Board of Directors shall amount to SEK 955,000 to be distributed as follows: SEK 375,000 to the Chairman of the Board and SEK 145,000 to each of the other Board members elected by the Annual General Meeting. Remuneration to the Auditor is paid in accordance with approved invoices.<\/p>\n

The Annual General Meeting resolved to re-elect Lars Kvarnhem, Per Carlsson, Victor Steien and Yonna Olsson as members of the Board of Directors and to elect Jens Viebke as a new member of the Board of Directors. Lars Kvarnhem was elected Chairman of the Board. The Annual General Meeting also resolved to re-elect R\u00e5dek AB as the company's Auditor, with Johan Rudengren as auditor in charge, for the period until the end of the next Annual General Meeting.<\/p>\n

The Annual General Meeting resolved to approve the proposed principals for appointing the Nomination Committee.<\/p>\n

The Annual General Meeting resolved to approve the Board of Directors' proposal regarding the remuneration policy for senior executives.<\/p>\n

The Annual General Meeting resolved to authorise the Board of Directors to issue new shares. Such share issues may deviate from the shareholder\u2019s preferential rights to subscribe for new shares. The issue of new shares may only increase the total number of shares by 900,000 shares, meaning around 10 % of the total number of shares in the company.<\/p>\n

The Annual General Meeting resolved to adopt new Articles of Association to enable the company to hold General Meetings either digitally or both physically and digitally. The new Articles of Association allow the Board of Directors to resolve that the General Meeting may be held digitally, to resolve on the collection of proxies, to resolve on postal voting as well as other adjustments necessary to the Board of Directors.<\/p>\n

Torsh\u00e4lla, May 8th, 2024.<\/p>\n<\/div>\n

\n

Contact Details<\/strong>
Torbj\u00f6rn Sk\u00f6ld<\/strong>
CEO & President
+46 (0)70 316 63 91 | torbjorn.skold@stille.se<\/a><\/p>\n<\/div>\n

\n

About Us<\/strong>
Stille AB (publ) develops, manufactures and markets medical devices<\/strong> for surgeons across the world. Stille was founded in 1841 and is one of the world\u2019s oldest medical device companies. Stille\u2019s main business areas are surgical instruments and c-arm tables. Stille\u2019s surgical instruments are mostly used during different kinds of open surgery. During minimal invasive procedures. the c-arm tables imagiQ2 and Medstone are key products. The company has a strong brand and products of a renowned high-quality. The share is listed on First North Growth Market under the acronym \u201cSTIL\u201d with Eminova AB as Certified Adviser, Eminova Fondkommission AB, + 46 8 684 211 10, adviser@eminova.se. For more information, visit www.stille.se<\/a>.<\/p>\n<\/div>\n

\n

Attachments<\/strong>
Report from the Annual General Meeting 2024 in Stille<\/a><\/p>\n<\/div>\n